104 related articles for article (PubMed ID: 27458253)
21. IGF2 is Deregulated During the Development of Uterine Cervical Carcinoma in Indian Patients.
Roychowdhury A; Samadder S; Indra Mazumder D; Das P; Basu M; Mondal R; Roy A; Roychoudhury S; Panda CK
Biochem Genet; 2019 Oct; 57(5):638-651. PubMed ID: 30949792
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
23. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
Simpson KL; Jones A; Norman S; Holmes CH
Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
[TBL] [Abstract][Full Text] [Related]
24. [Studies on pathogenesis of cervical carcinoma based on the analysis of growth and differentiation mechanism of cervical epithelium].
Konishi I
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):812-22. PubMed ID: 2172418
[TBL] [Abstract][Full Text] [Related]
25. P16INK4A and MIB-1: an immunohistochemical expression in preneoplasia and neoplasia of the cervix.
Srivastava S
Indian J Pathol Microbiol; 2010; 53(3):518-24. PubMed ID: 20699515
[TBL] [Abstract][Full Text] [Related]
26. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
27. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia.
Krishnappa P; Mohamad IB; Lin YJ; Barua A
Diagn Pathol; 2014 Nov; 9():202. PubMed ID: 25361681
[TBL] [Abstract][Full Text] [Related]
28. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
30. Association of aberrant methylation at promoter regions of tumor suppressor genes with placental pathologies.
Rahat B; Thakur S; Hamid A; Bagga R; Kaur J
Epigenomics; 2016 Jun; 8(6):767-87. PubMed ID: 27337502
[TBL] [Abstract][Full Text] [Related]
31. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
[TBL] [Abstract][Full Text] [Related]
32. Patterns of mRNA for epidermal growth factor receptor and keratin B-2 in normal cervical epithelium and in cervical intraepithelial neoplasia.
Mittal K; Pearson J; Demopoulos R
Gynecol Oncol; 1990 Aug; 38(2):224-9. PubMed ID: 1696918
[TBL] [Abstract][Full Text] [Related]
33. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
[TBL] [Abstract][Full Text] [Related]
34. Localization of human epidermal growth factor receptor in cervical intraepithelial neoplasias.
Göppinger A; Wittmaack FM; Wintzer HO; Ikenberg H; Bauknecht T
J Cancer Res Clin Oncol; 1989; 115(3):259-63. PubMed ID: 2753927
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium.
Kohlberger PD; Kieback DG; Bancher D; Stickeler E; Heinzl H; Gitsch G; Breitenecker G; Kainz C
Gynecol Oncol; 1997 Aug; 66(2):227-32. PubMed ID: 9264567
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of Rb1, cyclin D1 and p16 immunohistochemistry expression to distinguish lung small-cell carcinoma and large-cell neuroendocrine carcinoma.
Papaxoinis G; Bille A; McLean E; Nonaka D
Histopathology; 2022 Aug; 81(2):205-214. PubMed ID: 35544410
[TBL] [Abstract][Full Text] [Related]
37.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical investigations of steroid receptors in normal and neoplastic squamous epithelium of the uterine cervix.
Mosny DS; Herholz J; Degen W; Bender HG
Gynecol Oncol; 1989 Dec; 35(3):373-7. PubMed ID: 2599474
[TBL] [Abstract][Full Text] [Related]
39. Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian population.
Thakur N; Hussain S; Nasare V; Das BC; Basir SF; Bharadwaj M
Mol Biol Rep; 2012 Jan; 39(1):407-14. PubMed ID: 21567202
[TBL] [Abstract][Full Text] [Related]
40. [Cervix dysplasias: study of Rb and p53 gene expression and correlation with mitotic activity].
Mathevet P; Frappart L; Hittelman W
Gynecol Obstet Fertil; 2000 Jan; 28(1):44-50. PubMed ID: 10774117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
